2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide

C119H164Cl2N24O15 — CID 158494466

IUPAC2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide
SMILESCC(C)NC(=O)Cn1c(-c2cccc(Cl)c2)ncc(C(=O)NCCCN2CCCCC2)c1=O.CC(C)NC(=O)Cn1c(-c2ccccc2)ccc(C(=O)NCCc2ccccn2)c1=O.CNCC1CCN(c2ncc(C3C=CC=C(OC)C3)n(CC(=O)NC(C)C)c2=O)CC1.COc1cccc(-c2cnc(N3CCC(CCN(C)C)CC3)c(=O)n2CC(=O)NC(C)C)c1.COc1cccc(C2=C(Cl)NC(NCCC3CCNCC3)C(=O)N2CC(=O)NC(C)C)c1
InChIInChI=1S/C25H37N5O3.C24H32ClN5O3.C24H26N4O3.C23H34ClN5O3.C23H35N5O3/c1-18(2)27-23(31)17-30-22(20-7-6-8-21(15-20)33-5)16-26-24(25(30)32)29-13-10-19(11-14-29)9-12-28(3)4;1-17(2)28-21(31)16-30-22(18-8-6-9-19(25)14-18)27-15-20(24(30)33)23(32)26-10-7-13-29-11-4-3-5-12-29;1-17(2)27-22(29)16-28-21(18-8-4-3-5-9-18)12-11-20(24(28)31)23(30)26-15-13-19-10-6-7-14-25-19;1-15(2)27-19(30)14-29-20(17-5-4-6-18(13-17)32-3)21(24)28-22(23(29)31)26-12-9-16-7-10-25-11-8-16;1-16(2)26-21(29)15-28-20(18-6-5-7-19(12-18)31-4)14-25-22(23(28)30)27-10-8-17(9-11-27)13-24-3/h6-8,15-16,18-19H,9-14,17H2,1-5H3,(H,27,31);6,8-9,14-15,17H,3-5,7,10-13,16H2,1-2H3,(H,26,32)(H,28,31);3-12,14,17H,13,15-16H2,1-2H3,(H,26,30)(H,27,29);4-6,13,15-16,22,25-26,28H,7-12,14H2,1-3H3,(H,27,30);5-7,14,16-18,24H,8-13,15H2,1-4H3,(H,26,29)
InChIKeyHJCJHFYUCDFKNJ-UHFFFAOYSA-N
MW2241.68 g/mol
LogP11.31
Rot. Bonds43

About 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide

2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide (PubChem CID 158494466) has the molecular formula C119H164Cl2N24O15 and a molecular weight of 2241.68 g/mol. Its IUPAC name is 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide.

Molecular Properties

Compound Name2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide
PubChem CID158494466
Molecular FormulaC119H164Cl2N24O15
Molecular Weight2241.68 g/mol
Exact Mass2239.22
IUPAC Name2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide
SMILESCC(C)NC(=O)Cn1c(-c2cccc(Cl)c2)ncc(C(=O)NCCCN2CCCCC2)c1=O.CC(C)NC(=O)Cn1c(-c2ccccc2)ccc(C(=O)NCCc2ccccn2)c1=O.CNCC1CCN(c2ncc(C3C=CC=C(OC)C3)n(CC(=O)NC(C)C)c2=O)CC1.COc1cccc(-c2cnc(N3CCC(CCN(C)C)CC3)c(=O)n2CC(=O)NC(C)C)c1.COc1cccc(C2=C(Cl)NC(NCCC3CCNCC3)C(=O)N2CC(=O)NC(C)C)c1
InChIInChI=1S/C25H37N5O3.C24H32ClN5O3.C24H26N4O3.C23H34ClN5O3.C23H35N5O3/c1-18(2)27-23(31)17-30-22(20-7-6-8-21(15-20)33-5)16-26-24(25(30)32)29-13-10-19(11-14-29)9-12-28(3)4;1-17(2)28-21(31)16-30-22(18-8-6-9-19(25)14-18)27-15-20(24(30)33)23(32)26-10-7-13-29-11-4-3-5-12-29;1-17(2)27-22(29)16-28-21(18-8-4-3-5-9-18)12-11-20(24(28)31)23(30)26-15-13-19-10-6-7-14-25-19;1-15(2)27-19(30)14-29-20(17-5-4-6-18(13-17)32-3)21(24)28-22(23(29)31)26-12-9-16-7-10-25-11-8-16;1-16(2)26-21(29)15-28-20(18-6-5-7-19(12-18)31-4)14-25-22(23(28)30)27-10-8-17(9-11-27)13-24-3/h6-8,15-16,18-19H,9-14,17H2,1-5H3,(H,27,31);6,8-9,14-15,17H,3-5,7,10-13,16H2,1-2H3,(H,26,32)(H,28,31);3-12,14,17H,13,15-16H2,1-2H3,(H,26,30)(H,27,29);4-6,13,15-16,22,25-26,28H,7-12,14H2,1-3H3,(H,27,30);5-7,14,16-18,24H,8-13,15H2,1-4H3,(H,26,29)
InChIKeyHJCJHFYUCDFKNJ-UHFFFAOYSA-N
XLogP11.31
TPSA452.34 Ų
H-Bond Donors11
H-Bond Acceptors31
Rotatable Bonds43
Heavy Atoms160
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002241.68
LogP ≤ 511.31
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'}

Analyze 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide?
The IUPAC name of 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide (CID 158494466) is 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide.
What is the SMILES notation for 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide?
The canonical SMILES for 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide is CC(C)NC(=O)Cn1c(-c2cccc(Cl)c2)ncc(C(=O)NCCCN2CCCCC2)c1=O.CC(C)NC(=O)Cn1c(-c2ccccc2)ccc(C(=O)NCCc2ccccn2)c1=O.CNCC1CCN(c2ncc(C3C=CC=C(OC)C3)n(CC(=O)NC(C)C)c2=O)CC1.COc1cccc(-c2cnc(N3CCC(CCN(C)C)CC3)c(=O)n2CC(=O)NC(C)C)c1.COc1cccc(C2=C(Cl)NC(NCCC3CCNCC3)C(=O)N2CC(=O)NC(C)C)c1.
What is the InChIKey of 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide?
The InChIKey is HJCJHFYUCDFKNJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H37N5O3.C24H32ClN5O3.C24H26N4O3.C23H34ClN5O3.C23H35N5O3/c1-18(2)27-23(31)17-30-22(20-7-6-8-21(15-20)33-5)16-26-24(25(30)32)29-13-10-19(11-14-29)9-12-28(3)4;1-17(2)28-21(31)16-30-22(18-8-6-9-19(25)14-18)27-15-20(24(30)33)23(32)26-10-7-13-29-11-4-3-5-12-29;1-17(2)27-22(29)16-28-21(18-8-4-3-5-9-18)12-11-20(24(28)31)23(30)26-15-13-19-10-6-7-14-25-19;1-15(2)27-19(30)14-29-20(17-5-4-6-18(13-17)32-3)21(24)28-22(23(29)31)26-12-9-16-7-10-25-11-8-16;1-16(2)26-21(29)15-28-20(18-6-5-7-19(12-18)31-4)14-25-22(23(28)30)27-10-8-17(9-11-27)13-24-3/h6-8,15-16,18-19H,9-14,17H2,1-5H3,(H,27,31);6,8-9,14-15,17H,3-5,7,10-13,16H2,1-2H3,(H,26,32)(H,28,31);3-12,14,17H,13,15-16H2,1-2H3,(H,26,30)(H,27,29);4-6,13,15-16,22,25-26,28H,7-12,14H2,1-3H3,(H,27,30);5-7,14,16-18,24H,8-13,15H2,1-4H3,(H,26,29).
What are the key properties of 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide?
2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide has a molecular weight of 2241.68 g/mol, XLogP of 11.31, 43 rotatable bonds, 11 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[6-chloro-5-(3-methoxyphenyl)-3-oxo-2-(2-piperidin-4-ylethylamino)-1,2-dihydropyrazin-4-yl]-N-propan-2-ylacetamide;2-(3-chlorophenyl)-6-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-N-(3-piperidin-1-ylpropyl)pyrimidine-5-carboxamide;2-[3-[4-[2-(dimethylamino)ethyl]piperidin-1-yl]-6-(3-methoxyphenyl)-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-[6-(5-methoxycyclohexa-2,4-dien-1-yl)-3-[4-(methylaminomethyl)piperidin-1-yl]-2-oxopyrazin-1-yl]-N-propan-2-ylacetamide;2-oxo-1-[2-oxo-2-(propan-2-ylamino)ethyl]-6-phenyl-N-(2-pyridin-2-ylethyl)pyridine-3-carboxamide is sourced from PubChem (CID 158494466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).